Teva Pharm to market medical cannabis inhaler in Israel

JERUSALEM (Reuters) – Israel’s Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *